Consolidated Statements of Changes in Stockholders' Equity - USD ($)		Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Preferred Stock [Member] Series A Preferred Stock [Member]	Series A Preferred Stock [Member]	Total
Balance (in shares) at Dec. 31, 2015		8,118,939
Balance at Dec. 31, 2015		$ 8,119	$ 42,102,876	$ (42,152,618)			$ (41,623)
Stock Issued During Period, Shares, Acquisitions		1,861,503					1,861,503
Fair value of RestorGenex shares		$ 1,862	19,544,138				$ 19,546,000
Estimated fair value of RestorGenex stock options outstanding			1,321,000				1,321,000
Estimated fair value of RestorGenex warrants outstanding			384,000				$ 384,000
Stock Issued During Period, Shares, Issued for Services		148,073					45,643
Common stock issued for advisory services		$ 148	1,409,215				$ 1,409,363
Stock Issued During Period, Shares, Conversion of Convertible Securities		217,122					217,122
Conversion of convertible debt		$ 217	711,278				$ 711,495
Settlement of litigation matter upon issuance of convertible debt			2,500,000				2,500,000
Stock-based compensation expense			1,391,068				1,391,068
Net loss				(18,036,619)			(18,036,619)
Series A cumulative preferred dividend
Balance (in shares) at Dec. 31, 2016		10,345,637
Balance at Dec. 31, 2016		$ 10,346	69,363,575	(60,189,237)			$ 9,184,684
Stock Issued During Period, Shares, Issued for Services		17,606					17,606
Common stock issued for advisory services		$ 18	49,982				$ 50,000
Stock Issued During Period, Shares, Conversion of Convertible Securities		4,070,051			(4,070,051)
Conversion of convertible debt		$ 4,070	(4,070)
Stock-based compensation expense			1,240,551				1,240,551
Net loss				(1,364,518)			(1,364,518)
Cumulative effect of change in accounting principle (a)	[1]		1,134	(1,134)
Stock Issued During Period, Shares, New Issues					12,376,329
Reclassification of the fair market value of the Series A warrants			13,153,524				13,153,524
Series A cumulative preferred dividend			(1,252,394)			$ (1,252,394)	(1,252,394)
Stock Reclassified Upon Conversion of Preferred Stock, Shares		86,335				86,335
Reclassification of accrued dividends upon conversion of Series A		$ 86	189,994			$ 1,100,000	190,080
Beneficial conversion feature for accrued interest of convertible debt			28,017				28,017
Balance (in shares) at Dec. 31, 2017		14,519,629			8,306,278
Balance at Dec. 31, 2017		$ 14,520	$ 82,770,313	$ (61,554,889)			$ 21,229,944

[1] In 2017, the Company adopted provisions of ASU 2016-09, Improvements to Employee Share Based Payment Accounting, resulting in a cumulative effect adjustment to Accumulated Deficit and Additional Paid-in Capital for previously unrecognized stock-based compensation expense. See Note 3 for further discussion of the impacts of ASU 2016-09.